enGene Therapeutics Inc. - Common Shares (ENGN)
CUSIP: 29286M105
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 67,348,192
- Total 13F shares
- 58,699,543
- Share change
- +17,595,169
- Total reported value
- $530,008,548
- Price per share
- $9.03
- Number of holders
- 57
- Value change
- +$166,162,647
- Number of buys
- 41
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 29286M105?
CUSIP 29286M105 identifies ENGN - enGene Therapeutics Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29286M105:
Top shareholders of ENGN - enGene Therapeutics Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FCPM III SERVICES B.V. |
13F
|
Company |
—
mixed-class rows
|
12,510,709
mixed-class rows
|
$67,862,658 | — | 30 Sep 2025 | |
| Forbion Growth Opportunities Fund I Cooperatief U.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,798,362
|
$60,505,422 | — | 30 Oct 2024 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
10%
|
6,770,605
|
$47,123,411 | $0 | 11 Nov 2025 | |
| Fonds de solidarite des travailleurs et des travailleuses du Quebec |
3/4/5
13D/G
|
10%+ Owner |
4.5%
from 13D/G
|
3,036,153
|
$45,542,295 | — | 18 Apr 2024 | |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
7.1%
|
4,771,414
|
$39,984,449 | -$2,304,500 | 31 Dec 2025 | |
| Lumira Capital Investment Management Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,849,299
|
$38,492,990 | — | 20 Feb 2024 | |
| VR Adviser, LLC |
13F
|
Company |
7.5%
|
5,046,414
|
$34,467,008 | — | 30 Sep 2025 | |
| Kynam Capital Management, LP |
13F
13D/G
|
Company |
2.2%
from 13D/G
|
4,994,090
|
$34,109,635 | — | 30 Sep 2025 | |
| Cormorant Asset Management, LP |
13D/G
13F
|
Company |
6%
|
4,000,000
|
$33,520,000 | $0 | 31 Dec 2025 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
6.7%
|
4,317,332
|
$30,048,631 | +$14,462,734 | 11 Nov 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
—
mixed-class rows
|
3,314,206
mixed-class rows
|
$22,415,095 | — | 30 Sep 2025 | |
| BRAIDWELL LP |
13F
|
Company |
3.4%
|
2,266,319
|
$15,478,959 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
1,208,399
|
$8,253,366 | — | 30 Sep 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.7%
|
1,157,380
|
$7,904,905 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.5%
|
1,038,000
|
$7,089,540 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.5%
|
1,000,000
|
$6,830,000 | — | 30 Sep 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
3%
|
1,528,768
|
$6,115,072 | $0 | 31 Dec 2024 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
1.1%
|
747,750
|
$5,107,133 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
647,492
mixed-class rows
|
$4,420,534 | — | 30 Sep 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
1.8%
|
945,402
|
$3,781,608 | -$8,424,148 | 27 Jan 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
—
mixed-class rows
|
616,059
mixed-class rows
|
$3,658,456 | — | 30 Sep 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.79%
|
530,299
|
$3,621,942 | — | 30 Sep 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.75%
|
504,409
|
$3,445,113 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.65%
|
435,291
|
$2,973,037 | — | 30 Sep 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.55%
|
370,000
|
$2,527,100 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.51%
|
343,928
|
$2,349,028 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
147,602
|
$1,008,122 | — | 30 Sep 2025 | |
| BVF INC/IL |
13F
|
Company |
—
class O/S missing
|
945,402
|
$680,689 | — | 30 Sep 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.11%
|
77,000
|
$525,910 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
58,370
|
$398,667 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
30,295
|
$206,915 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
29,018
|
$198,192 | — | 30 Sep 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.04%
|
25,070
|
$171,226 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
20,502
|
$140,029 | — | 30 Sep 2025 | |
| Saba Capital Management, L.P. |
13F
|
Company |
—
class O/S missing
|
178,334
|
$127,509 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
17,910
|
$122,325 | — | 30 Sep 2025 | |
| Pale Fire Capital SE |
13F
|
Company |
0.03%
|
17,254
|
$117,845 | — | 30 Sep 2025 | |
| Calamos Advisors LLC |
13F
|
Company |
—
class O/S missing
|
150,000
|
$108,000 | — | 30 Sep 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.02%
|
11,074
|
$75,635 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
104,622
|
$75,328 | — | 30 Sep 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
—
mixed-class rows
|
10,101
mixed-class rows
|
$68,372 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.01%
|
10,000
|
$68,300 | — | 30 Sep 2025 | |
| Philip Astley-Sparke |
3/4/5
|
Director |
—
mixed-class rows
|
65,000
mixed-class rows
|
$65,000 | — | 08 Jul 2025 | |
| PFS Partners, LLC |
13F
|
Company |
0.01%
|
9,000
|
$61,470 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
7,915
|
$54,000 | — | 30 Sep 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
59,431
|
$42,196 | — | 30 Sep 2025 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. |
13F
|
Company |
—
class O/S missing
|
55,243
|
$39,223 | — | 30 Sep 2025 | |
| WHITEBOX ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
31,000
|
$22,010 | — | 30 Sep 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
—
class O/S missing
|
19,049
|
$13,715 | — | 30 Sep 2025 | |
| CSS LLC/IL |
13F
|
Company |
—
class O/S missing
|
16,895
|
$11,995 | — | 30 Sep 2025 |
Institutional Holders of enGene Therapeutics Inc. - Common Shares (ENGN) as of Q4 2025
As of 31 Dec 2025,
enGene Therapeutics Inc. - Common Shares (ENGN) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,699,543 shares.
The largest 10 holders included
FCPM III SERVICES B.V., PERCEPTIVE ADVISORS LLC, VR ADVISER, LLC, Deep Track Capital, LP, Cormorant Asset Management, LP, Blue Owl Capital Holdings LP, Siren, L.L.C., BRAIDWELL LP, Nextech Invest, Ltd., and JANUS HENDERSON GROUP PLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
37
Q4 2025 holders
57
Holder diff
20
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.